시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
요실금 및 골반장기탈출증 기기 및 장비 시장 보고서(2026년)
Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Global Market Report 2026
상품코드 : 1939170
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,777,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,796,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,815,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

요실금 및 골반장기탈출증 치료 기기·장비 시장 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 40억 6,000만 달러에서 2026년에는 42억 8,000만 달러로, CAGR 5.4%로 확대가 전망되고 있습니다. 지난 수년간 요실금 질환 발생률 증가, 골반 건강 상태에 대한 인식 증가, 임상 치료 옵션 증가, 요실금 관리용 의료기기의 보급 확대, 부인과 의료 서비스 확대 등이 성장 요인으로 꼽히고 있습니다.

요실금 및 골반장기탈출증 치료 기기·장비 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 53억 9,000만 달러에 달하며, CAGR은 6.0%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 전 세계 고령화 인구 증가, 비침습적 치료법 선호도 증가, 재택치료 도입 확대, 여성 건강 기술에 대한 투자 증가, 첨단 골반저부 재활 장비에 대한 수요 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 저침습적 치료기기의 도입 증가, 비수술적 치료 솔루션에 대한 수요 증가, 전기자극요법 사용 증가, 환자 중심의 가정용 기기 보급 확대, 편안함과 생체적합성에 대한 관심 증가 등을 들 수 있습니다.

고령화 인구 증가는 향후 수년간 요실금 및 골반장기 탈치료 기기 및 장치 시장의 성장을 촉진할 것으로 예측됩니다. 고령화 인구는 65세 이상의 개인을 의미하며, 그 확대는 주로 의료기술의 발전과 생활수준의 향상으로 인한 평균수명 연장에 기인합니다. 노년층은 노화에 따른 골반저근 약화, 호르몬 변화, 동반질환 등의 영향으로 요실금, 골반장기탈출증 등의 증상이 발생하기 쉬워 이러한 질환을 관리할 수 있는 전문 의료기기 및 장비에 대한 수요가 증가하고 있습니다. 예를 들어 노인 권리에 초점을 맞춘 비정부기구인 헬프 에이지 인터내셔널(HelpAge International)에 따르면 2023년 10월 기준 2050년까지 전 세계 노인 인구의 약 80%가 중저소득 국가에 거주할 것으로 예측했습니다. 이러한 노인 인구의 급속한 증가는 전 세계에서 요실금 및 골반장기탈출증에 대한 의료기기 및 장치에 대한 수요를 크게 증가시키고 있습니다.

요실금 및 골반장기탈출증 기기 및 장치 시장에서 활동하는 주요 기업은 편안함, 치료 효과, 장기적인 골반저 기능 개선을 위해 환자별 맞춤화, 정밀한 해부학적 모델링, 첨단 3D 프린팅 기술, 비침습적 치료 지원 솔루션과 같은 기술적 진보를 중요시하고 있습니다. 의료진은 환자별 맞춤형 장치 맞춤화를 통해 개인의 해부학적 특징에 맞는 페서리 및 지지 장치를 설계할 수 있으며, 적합성 향상, 합병증 감소, 시행착오에 의한 피팅 방식에 대한 의존도 감소를 실현할 수 있습니다. 예를 들어 2024년 3월 캐나다에 본사를 둔 여성 건강 기술 기업 코스메 메디컬(Cosm Medical)은 골반 장기 탈관리의 변혁을 목표로 하는 첨단 3D 프린팅 페서리 솔루션 'Gynethotics(Gynethotics)'를 발표했습니다. Gynethotics는 환자의 골반 구조에 대한 상세한 디지털 측정 데이터를 활용하여 기존 페서리에 비해 편안함, 안정성, 치료 효과를 향상시킨 맞춤형 지지대를 제공합니다. 비랄 이프티카 추그타이 박사는 이 개별화된 접근법은 환자 만족도를 크게 향상시키고, 적응 과정을 간소화하며, 침습적 수술의 필요성을 줄일 수 있는 잠재력을 가지고 있으며, 비수술적 골반저 치료의 중요한 진전을 의미한다고 말했습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 방글라데시 시장

제19장 태국 시장

제20장 베트남 시장

제21장 말레이시아 시장

제22장 싱가포르 시장

제23장 필리핀 시장

제24장 홍콩 시장

제25장 뉴질랜드 시장

제26장 대만 시장

제27장 동남아시아 시장

제28장 서유럽 시장

제29장 영국 시장

제31장 프랑스 시장

제32장 이탈리아 시장

제33장 스페인 시장

제34장 오스트리아 시장

제35장 벨기에 시장

제36장 덴마크 시장

제37장 핀란드 시장

제38장 아일랜드 시장

제39장 네덜란드 시장

제40장 노르웨이 시장

제41장 포르투갈 시장

제42장 스웨덴 시장

제42장 스위스 시장

제43장 동유럽 시장

제44장 러시아 시장

제45장 체코 시장

제46장 폴란드 시장

제47장 루마니아 시장

제48장 우크라이나 시장

제49장 북미 시장

제50장 미국 시장

제51장 캐나다 시장

제52장 멕시코 시장

제53장 남미 시장

제54장 브라질 시장

제55장 칠레 시장

제56장 아르헨티나 시장

제57장 콜롬비아 시장

제58장 페루 시장

제59장 중동 시장

제60장 사우디아라비아 시장

제61장 이스라엘 시장

제62장 이란 시장

제63장 튀르키예 시장

제64장 아랍에미리트 시장

제65장 아프리카 시장

제66장 이집트 시장

제67장 나이지리아 시장

제68장 남아프리카공화국 시장

제69장 시장 규제 상황과 투자환경

제70장 경쟁 구도와 기업 개요

제71장 기타 대기업과 혁신적 기업

제72장 세계의 시장 경쟁 벤치마킹과 대시보드

제73장 주요 합병과 인수

제74장 시장의 잠재력이 높은 국가, 부문, 전략

제75장 부록

KSA
영문 목차

영문목차

Urinary incontinence & pelvic organ prolapse devices and equipment are used in the treatment of pelvic organ prolapse and urinary incontinence. Urinary incontinence (UI), also known as involuntary urination, is defined as uncontrolled leakage of urine caused by an overactive bladder. Pelvic organ prolapse (POP) is caused by defects in the supporting structures of the vagina.

These devices can be categorized into two main types such as urinary incontinence devices and pelvic organ prolapse devices. Urinary incontinence devices encompass items like artificial urinary sphincters, electrical stimulation devices, urethral slings, and catheters, which are utilized to address urinary incontinence. In contrast, pelvic organ prolapse devices include vaginal mesh and vaginal pessaries, designed to manage pelvic organ prolapse. Urinary incontinence can manifest in various forms, including stress incontinence, urge incontinence, overflow incontinence, and functional incontinence. These devices find applications across different healthcare settings, such as hospitals, clinics, ambulatory surgical centers, and for at-home use.

Tariffs are influencing the urinary incontinence and pelvic organ prolapse devices market by increasing costs of imported medical-grade polymers, electronic stimulation components, surgical implants, and precision manufacturing equipment. Healthcare providers in North America and Europe are most affected due to reliance on imported specialized devices, while Asia-Pacific faces higher production costs for export-focused manufacturing. These tariffs are contributing to higher device prices and procurement delays. However, they are also promoting domestic manufacturing, localized sourcing of medical components, and innovation in cost-effective treatment solutions.

The urinary incontinence & pelvic organ prolapse devices and equipment market research report is one of a series of new reports from The Business Research Company that provides urinary incontinence & pelvic organ prolapse devices and equipment market statistics, including urinary incontinence & pelvic organ prolapse devices and equipment industry global market size, regional shares, competitors with a urinary incontinence & pelvic organ prolapse devices and equipment market share, detailed urinary incontinence & pelvic organ prolapse devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the urinary incontinence & pelvic organ prolapse devices and equipment industry. This urinary incontinence & pelvic organ prolapse devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The urinary incontinence & pelvic organ prolapse devices and equipment market size has grown strongly in recent years. It will grow from $4.06 billion in 2025 to $4.28 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to rising incidence of urinary incontinence disorders, growing awareness of pelvic health conditions, increased availability of clinical treatment options, wider acceptance of medical devices for ui management, expansion of gynecological care services.

The urinary incontinence & pelvic organ prolapse devices and equipment market size is expected to see strong growth in the next few years. It will grow to $5.39 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing aging population globally, rising preference for non-invasive therapies, expansion of home healthcare adoption, growing investments in women's health technologies, increasing demand for advanced pelvic floor rehabilitation devices. Major trends in the forecast period include increasing adoption of minimally invasive treatment devices, rising demand for non-surgical management solutions, growing use of electrical stimulation therapies, expansion of patient-centric home-use devices, enhanced focus on comfort and biocompatibility.

The growing geriatric population is expected to drive the growth of the urinary incontinence and pelvic organ prolapse devices and equipment market in the coming years. The geriatric population refers to individuals aged 65 years and older, and its expansion is largely attributed to increased life expectancy resulting from advances in healthcare and improved living standards. Older adults are more susceptible to conditions such as urinary incontinence and pelvic organ prolapse due to age-related weakening of pelvic floor muscles, hormonal changes, and comorbidities, thereby increasing the need for specialized medical devices and equipment to manage these disorders. For instance, in October 2023, according to HelpAge International, a non-governmental organization focused on the rights of older people, it is projected that by 2050, around 80% of the world's older population will be living in low- and middle-income countries. This rapid growth in the elderly population is significantly boosting demand for urinary incontinence and pelvic organ prolapse devices and equipment globally.

Major companies operating in the urinary incontinence and pelvic organ prolapse devices and equipment market are emphasizing technological advancements such as patient-specific device customization, precise anatomical modeling, advanced 3D printing, and non-invasive therapeutic support solutions to improve comfort, treatment effectiveness, and long-term pelvic floor outcomes. Patient-specific device customization allows healthcare providers to design pessaries and support devices tailored to an individual's unique anatomy, resulting in better fit, fewer complications, and reduced reliance on trial-and-error fitting methods. For instance, in March 2024, Cosm Medical, a Canada-based women's health technology company, introduced an advanced 3D-printed pessary solution called Gynethotics, aimed at transforming pelvic organ prolapse management. By utilizing detailed digital measurements of a patient's pelvic anatomy, Gynethotics provides custom-fitted support devices that deliver enhanced comfort, stability, and therapeutic performance compared to conventional pessaries. According to Dr. Bilal Iftikhar Chughtai, this personalized approach has the potential to substantially improve patient satisfaction, simplify the fitting process, and lower the need for invasive surgical procedures, representing a significant advancement in non-surgical pelvic floor care.

In September 2023, Caldera Medical, Inc., a U.S.-based women's health medical device company, acquired Atlantic Therapeutics for an undisclosed amount. Through this acquisition, Caldera Medical aims to broaden its women's health portfolio by integrating Atlantic Therapeutics' non-invasive, FDA-cleared Innovo pelvic floor strengthening technology, strengthening its portfolio of first-line therapies for stress urinary incontinence. Innovo uses advanced neuromuscular electrical stimulation to strengthen pelvic floor muscles without the need for internal probes, offering a clinically proven, patient-friendly treatment option. Atlantic Therapeutics is an Ireland-based company specializing in non-invasive pelvic floor strengthening and neuromuscular stimulation solutions for women.

Major companies operating in the urinary incontinence & pelvic organ prolapse devices and equipment market are Boston Scientific Corporation, Coloplast A/S, Ethicon US, Becton Dickinson and Company, Johnson & Johnson, Teleflex Incorporated, Medtronic plc, COVIDien, Cook Medical, Neomedic International, CooperSurgical, MedGyn, Personal Medical Corp, Integra LifeSciences, Panpac Medical, Medesign, Smiths Medical Inc., Thomas Medical, Kangge Medical, Dr. Arabin GmbH & Co. KG, American Medical Systems Inc., Caldera Medical Inc., Intuitive Surgical, InControl Medical LLC, Atlantic Therapeutics Ltd., Axonics Modulation Technologies, Convatec Group plc, Laborie, NUVO Group, Pelvalon, pfm medical, Promedon, Prosurg Inc., UROMED Kurt Drews KG, Verathon Inc., Vitality Medical, Women's Choice Pharmaceuticals, Zimmer Biomet Holdings Inc.

North America was the largest region in the urinary incontinence & pelvic organ prolapse devices and equipment market in 2025. Western Europe was the second-largest region in the urinary incontinence & pelvic organ prolapse devices and equipment market report. The regions covered in the urinary incontinence & pelvic organ prolapse devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the urinary incontinence & pelvic organ prolapse devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

The urinary incontinence & pelvic organ prolapse devices and equipment market consist of sales of artificial urinary sphincters, electrical stimulation devices, urethral slings, and catheters that are used for the treatment of pelvic organ prolapse and urinary incontinence. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses urinary incontinence & pelvic organ prolapse devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for urinary incontinence & pelvic organ prolapse devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The urinary incontinence & pelvic organ prolapse devices and equipment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Characteristics

3. Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Supply Chain Analysis

4. Global Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Trends And Strategies

5. Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Analysis Of End Use Industries

6. Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Total Addressable Market (TAM) Analysis for the Market

9. Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Segmentation

10. Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Regional And Country Analysis

11. Asia-Pacific Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

12. China Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

13. India Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

14. Japan Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

15. Australia Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

16. Indonesia Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

17. South Korea Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

18. Bangladesh Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

19. Thailand Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

20. Vietnam Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

21. Malaysia Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

22. Singapore Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

23. Philippines Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

24. Hong Kong Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

25. New Zealand Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

26. Taiwan Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

27. South East Asia Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

28. Western Europe Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

29. UK Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

31. France Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

32. Italy Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

33. Spain Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

34. Austria Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

35. Belgium Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

36. Denmark Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

37. Finland Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

38. Ireland Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

39. Netherlands Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

40. Norway Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

41. Portugal Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

42. Sweden Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

42. Switzerland Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

43. Eastern Europe Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

44. Russia Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

45. Czech Republic Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

46. Poland Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

47. Romania Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

48. Ukraine Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

49. North America Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

50. USA Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

51. Canada Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

52. Mexico Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

53. South America Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

54. Brazil Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

55. Chile Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

56. Argentina Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

57. Colombia Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

58. Peru Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

59. Middle East Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

60. Saudi Arabia Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

61. Israel Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

62. Iran Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

63. Turkey Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

64. United Arab Emirates Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

65. Africa Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

66. Egypt Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

67. Nigeria Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

68. South Africa Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

69. Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Regulatory and Investment Landscape

70. Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Competitive Landscape And Company Profiles

71. Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Other Major And Innovative Companies

72. Global Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Competitive Benchmarking And Dashboard

73. Key Mergers And Acquisitions In The Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market

74. Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market High Potential Countries, Segments and Strategies

75. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기